Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Nora St Victor Dély, MD, Ofelia A. Alvarez, MD, Vanessa J Dor, MD, Emmeline Lerebours, MD

Blood (2019) 134 (Supplement_1): 2306.

https://doi.org/10.1182/blood-2019-124105

Published: 2019

Journal Articles

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Irina Demmer, Susanne Huschens, Dietrich Potthoff, Jörg Tomeczkowski, Christian Englisch, Pushpike Thilakarathne, Joris Diels, Shaji K. Kumar, MD, Brian GM Durie, MD, Lewin Eisele

Blood (2018) 132 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2018-99-116884

Published: 2018

Journal Articles

Evaluation of Infusion Reactions in Patients Receiving Daratumumab Post-Implementation of an Augmented Pre- and Peri-Medication Regimen

Patrick McBride, PharmD, Houry Leblebjian, PharmD, Paul Richardson, Jacob Laubach, MD, Hillary Prescott, PharmD

Blood (2018) 132 (Supplement 1): 3234.

https://doi.org/10.1182/blood-2018-99-111361

Published: 2018

Journal Articles

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Jordan K. Schaefer, MD, Zhenke Wu, PhD, Mengbing Li, Jennifer J Griggs, MD MPH, Suman L. Sood, MD

Blood (2018) 132 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2018-99-117931

Published: 2018

Journal Articles

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Catherine Mupela Chunda-Liyoka, MD MSc, Ashok A Kumar, PhD BS, MS, Pauline M Sambo, MD, Felicity Lubinda, Tyler Humpton, Pauline Okuku, MSc, Chimuka Miyanda, Bsc, Justine Mulindwa, MD, Judy Im I, Kerry Maguire, MPH, George M Whitesides, Prof., Thomas P. Stossel, MD

Blood (2018) 132 (Supplement 1): 316.

https://doi.org/10.1182/blood-2018-99-114625

Published: 2018

Journal Articles

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Nana Oduraa Addo-Tabiri, MD PhD, Rani Chudasama, MD, Rhythm Vasudeva, MBChB, Orly Leiva, MD, Brenda Garcia, MD, Jonathan Ravid, BS, Bunze Tamala, BS, Linda Rosen, MSEE, Mostafa Belghasem, MD PhD, Janice Weinberg, PhD, Ryan Ferguson, MPH, Brett Johnson, PhD, Mary Brophy, MD MPH, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 496.

https://doi.org/10.1182/blood-2018-99-115605

Published: 2018

Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD

Blood (2018) 132 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2018-99-119720

Published: 2018

Journal Articles

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Nefeli Giannakopoulou, Marianna Politou, MD, Panagiotis Theodorou Diamantopoulos, MD PhD, Dimitris Korakakis, Maria Efstathopoulou, Theodora Kassi, Christina-Nefeli Kontandreopoulou, Katerina Zoi, PhD, Andreas Giannopoulos, BSc, MSc, Maria Dimou, Panayiotis Panayiotidis, MD PhD, Nora-Athina Viniou, MD

Blood (2018) 132 (Supplement 1): 4304.

https://doi.org/10.1182/blood-2018-99-116660

Published: 2018

Journal Articles

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Hyunkyung Park, MD, Youk Jeonghwan, Wan Beom Park, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Inho Kim, MD PhD, Kim Nam Joong, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Sung-Soo Yoon, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 5033.

https://doi.org/10.1182/blood.V130.Suppl_1.5033.5033

Published: 2017

Journal Articles

Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations

LaQuita M Jones, DO, Maureen M O'Brien, MD, Erin H. Breese, MD PhD, Karen Burns, MD, Jennifer Mangino, MD, Michael J. Absalon, MD PhD, Javier A. El-Bietar, MD, Michael Grimley, MD, Benjamin Mizukawa, MD, Lynn Lee, MD, John Peter Perentesis, MD, Christine L Phillips, MD

Blood (2017) 130 (Supplement 1): 3895.

https://doi.org/10.1182/blood.V130.Suppl_1.3895.3895

Published: 2017

Journal Articles

Coagulation Activation in Brain Neoplasms

Swaroopa Yerrabothala, MD, Brett L. Gourley, MD, James C Ford, PhD, Syed Rakin Ahmed, Stephen J Guerin, MD, Heather A Wishart, PhD, Camilo E Fadul, MD, Deborah L. Ornstein, MD

Blood (2017) 130 (Supplement 1): 3704.

https://doi.org/10.1182/blood.V130.Suppl_1.3704.3704

Published: 2017

Journal Articles

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

Małgorzata Dawidowska, PhD, Bronisława Szarzyńska-Zawadzka, Roman Jaksik, PhD, Monika Drobna, Maria Kosmalska, Sędek Łukasz, PhD, Tomasz Szczepański, MD PhD, Michał Witt, MD PhD

Blood (2017) 130 (Supplement 1): 1443.

https://doi.org/10.1182/blood.V130.Suppl_1.1443.1443

Published: 2017

Journal Articles

Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

Blood (2017) 130 (Supplement 1): 3181.

https://doi.org/10.1182/blood.V130.Suppl_1.3181.3181

Published: 2017

Journal Articles

Thrombin Generation As a Predictive Biomarker for Venous Thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Systemic Therapy

Michael Y. Cho, MD, Aderonke Ajala, MD, Lauren T. Salvatore, Deborah L. Ornstein, MD, Monic R. Drescher, MD

Blood (2017) 130 (Supplement 1): 1103.

https://doi.org/10.1182/blood.V130.Suppl_1.1103.1103

Published: 2017

Journal Articles

Published abstracts at international meetings often over- or underestimate the initial response rate

Ofrat Beyar-Katz, Jacob M. Rowe, Lauren E. Townsend, Martin S. Tallman, Rivka Hadomi, Netanel A. Horowitz

Blood (2017) 129 (16): 2326–2328.

https://doi.org/10.1182/blood-2017-01-763144

Published: 2017

Includes: Supplemental data

Journal Articles

Identification of a Novel Chromosomal Translocation t(11;16)(q23;q22) Fusing MLL to Enhancer of mRNA Decapping (EDC)-4 in Smoldering Acute Myeloid Leukemia

Heiko Becker, MD, Keisuke Kataoka, MD PhD, Gabriele Greve, Jesús Duque Afonso, MD, Tobias Ma, Sabine Bleul, Milena Pantic, PhD, Julia Schüler, DVM, PhD, Justus Duyster, MD, Michael L Cleary, MD, Seishi Ogawa, MD PhD, Michael Lübbert, MD

Blood (2016) 128 (22): 1696.

https://doi.org/10.1182/blood.V128.22.1696.1696

Published: 2016

Journal Articles

Prognostic Impact of Molecular Response Assessed By Next-Generation Sequencing in a Large Cohort of Multiple Myeloma Patients

Beatriz Sanchez-Vega, PhD, Rafael Alonso, MD, Isabel Cuenca, Santiago Barrio, PhD, Yanira Ruiz-Heredia, Carlos Marin, Inmaculada Rapado, PhD, Cristina Jimenez, BSc, Xabier Aguirre, Rosa M. Ayala, MD PhD, Teresa Cedena, Bruno Paiva, PhD, Maria-Victoria Mateos, MD PhD, Laura Rosiñol, Joan Bladé, Jesus San Miguel, MD PhD, Ramon Garcia-Sanz, MD PhD, Juan José Lahuerta, MDPhD, Joaquín Martínez-López, MD PhD

Blood (2016) 128 (22): 3283.

https://doi.org/10.1182/blood.V128.22.3283.3283

Published: 2016

Journal Articles

Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study

Blood (2016) 128 (22): 2288.

https://doi.org/10.1182/blood.V128.22.2288.2288

Published: 2016

Journal Articles

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Dilan Patel, MD, Jamie Riney, MD, Andrew Hahn, MD, Matthew K Stein, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1866.

https://doi.org/10.1182/blood.V128.22.1866.1866

Published: 2016

Journal Articles

Rivaroxaban Versus Fondaparinux in the Treatment of Superficial Vein Thrombosis - the Surprise Trial

Jan Beyer-Westendorf, MD, Sebastian Schellong, MD, Horst Gerlach, MD, Katja Jersemann, Eberhard Rabe, MD, Kurtulus Sahin, Rupert Bauersachs, MD PhD

Blood (2016) 128 (22): 85.

https://doi.org/10.1182/blood.V128.22.85.85

Published: 2016

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Evaluation of Infusion Reactions in Patients Receiving Daratumumab Post-Implementation of an Augmented Pre- and Peri-Medication Regimen

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations

Coagulation Activation in Brain Neoplasms

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

Thrombin Generation As a Predictive Biomarker for Venous Thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Systemic Therapy

Published abstracts at international meetings often over- or underestimate the initial response rate

Identification of a Novel Chromosomal Translocation t(11;16)(q23;q22) Fusing MLL to Enhancer of mRNA Decapping (EDC)-4 in Smoldering Acute Myeloid Leukemia

Prognostic Impact of Molecular Response Assessed By Next-Generation Sequencing in a Large Cohort of Multiple Myeloma Patients

Post-Remission Treatment with Autologous or Allogeneic Bone Marrow Transplantation or Intensive Chemotherapy in Younger AML Patients: Long-Term Follow-up Results of the EORTC/Gimema AML-8A Study

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Rivaroxaban Versus Fondaparinux in the Treatment of Superficial Vein Thrombosis - the Surprise Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only